1. Home
  2. BNTX vs SYF Comparison

BNTX vs SYF Comparison

Compare BNTX & SYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$98.56

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Logo Synchrony Financial

SYF

Synchrony Financial

HOLD

Current Price

$87.88

Market Cap

27.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTX
SYF
Founded
2008
1932
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
24.8B
27.9B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BNTX
SYF
Price
$98.56
$87.88
Analyst Decision
Buy
Buy
Analyst Count
11
21
Target Price
$137.40
$84.57
AVG Volume (30 Days)
1.1M
2.7M
Earning Date
11-03-2025
01-27-2026
Dividend Yield
N/A
1.37%
EPS Growth
N/A
18.70
EPS
N/A
9.10
Revenue
$3,698,814,972.00
$9,645,000,000.00
Revenue This Year
$2.03
$92.90
Revenue Next Year
N/A
$2.60
P/E Ratio
N/A
$9.64
Revenue Growth
3.70
7.08
52 Week Low
$81.20
$40.55
52 Week High
$126.77
$88.53

Technical Indicators

Market Signals
Indicator
BNTX
SYF
Relative Strength Index (RSI) 56.16 67.75
Support Level $95.85 $83.28
Resistance Level $101.48 $88.53
Average True Range (ATR) 1.81 1.41
MACD 0.89 -0.00
Stochastic Oscillator 70.40 90.14

Price Performance

Historical Comparison
BNTX
SYF

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

Share on Social Networks: